DENVER — September 19, 2024 — ivWatch, LLC, the IV safety company, today announced its participation in this year’s Association for Vascular Access Conference at the Gaylord Rockies in Denver, Colorado, from September 28 – 30, 2024.
In addition to showcasing ivWatch’s patented IV patient monitoring technology at Booth 613, NHS vascular access specialist Andrew Barton will present recently published study results during his talk, How a UK NHS Hospital Strategy Improved Patient Safety and Reduced Extravasations, Making Infusion Therapy Safer, to be held on Sunday, September 29 from 4:45-5:45 pm in Summit 6/7. Barton will also be a guest in ivWatch’s booth to preview and share insights from his upcoming peer-reviewed paper Extravasation and Infiltration: Identifying best practices, improving patient safety, and reducing the economic burden in healthcare settings. Attendees will receive an advanced copy of the article which will be published on November 21 by the British Journal of Nursing.
ivWatch will also introduce Melissa Williams, a patient, mother, and painter who suffered an amputation due to an IV that extravasated post-surgery. She will share her 7-year unimaginable journey and participate in a live painting demonstration at ivWatch’s booth throughout the weekend.
ivWatch will hold a symposium on Sunday, September 29, from 7:00 am to 8:30 am., the details of which include:
Title of Session:
The Global IV Failure Epidemic: Realities of Extravasation and Infiltration Management
Panel:
Two billion patient IVs are inserted globally every year, serving as a lifeline that forms the bedrock of healthcare. Yet up to 50% fail, even in the most experienced hands, leading to negative patient outcomes.
Taking a proactive approach to infiltration and extravasation has been proven to reduce the severity of these events, while the standard reactive approach can cause patient harm. This session will introduce you to just one patient’s life that was turned upside down by an IV injury. It will also provide an overview of the causes and results of infiltration and extravasation globally from both clinical and patient perspectives. It also seeks to close the clinical education gap around IV injury prevention.
Nurse practitioners will discuss the implications for adult and pediatric patients, and a patient who suffered a severe IV injury will share her experience. Current infiltration, extravasation trends, and misconceptions from various geographies will also be discussed. Mimosas and breakfast will be served.
Speakers include:
Melissa Williams – a painter who sustained an IV injury resulting in the loss of fingers and a portion of her hand, tells the story of her courageous and challenging journey.
Sandy Conn – a pediatric cardiac ICU nurse and clinical coach helping staff see the global perspective of preventing serious harm at Cincinnati Children’s Hospital, outlines the next steps for clinicians to ensure that no patient will have to suffer as Melissa has and that healthcare organizations can save millions in damages from preventable IV injuries.
Andrew Barton – nurse consultant in IV therapy and vascular access at NHS Frimley Hospital in the United Kingdom, chair of the National Infusion and Vascular Access Society (NIVAS), and global committee member of the World Congress of Vascular Access (WoCoVA) discusses how infiltration or extravasation of various intravenous drugs and treatments vary in terms of patient harm and long-term outcomes. He will also discuss how impacts differ across varied medical units such as NICU to oncology to infusion centers.
Gary Warren – President and CEO of ivWatch, moderator, will share the global viewpoint of IV injury prevention and the varying causes and dangers associated with failure to monitor IV insertion in clinical environments adequately.
To learn more about the ivWatch patient monitoring system for IV infiltrations and extravasations, visit: https://www.ivwatch.com/tech-overview/.
About ivWatch, LLC
ivWatch, LLC is a biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is pioneering the use of optical sensors to detect adverse IV events early to minimize the risk of injury caused by infiltrations and extravasations. By using this technology, clinicians can leverage continuous monitoring to help identify infiltrations as early as possible. Our innovative IV monitoring solutions are backed by decades of clinical research and device development. To learn more, follow us on Twitter @ivWatch, Facebook @ivWatchLLC, Instagram @ivWatchLLC and LinkedIn @ivWatch-LLC, or visit www.ivWatch.com.